MYCN and cancer: Consistent with previous reports showing MYC proteins induce greater differential splicing when dysregulated in cancer cells [28, 31], our analysis using the leafcutter program [32] revealed that neuroblastoma cells overexpressing MYCN exhibited a greater number of differentially spliced genes compared to cells expressing no MYCN (lane 4 vs lane 1, Fig. 4A).